Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT02032134
Eligibility Criteria:
Inclusion Criteria:
Cryopreserved buffy coat pooled platelets will be infused, after being thawed, in inpatients at U.O. of Hematology -Policlinic "P. Giaccone"-Palermo, falling into one of the following categories:
* Stable clinical conditions and no complications with platelets ≤ 10,000/microliter;
* With active bleeding and ≤ 20,000 platelets/microliter;
* In the presence of: high blood pressure, high fever, rapid drop in platelets, infection, chemotherapy, coagulation abnormalities with ≤ 20,000 platelets/microliter.
Exclusion Criteria:
Patients
* Suffering from congenital immunodeficiency
* Allogeneic bone marrow transplant candidates
* Bone Marrow Donors for transplantation
* Undergoing bone marrow transplant or
* Suffering from Hodgkin's disease and treated with purine analogues (Fludarabine, cladribine)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02032134
Study Brief:
Protocol Section:
NCT02032134